Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events

As guidelines to treat the risk factors of cardiovascular disease continue to evolve, Michael Weber, MD, explains how new editions of lipid, diabetes, and hypertension guidelines continue to improve patient care.

Dr Weber explains that we should not expect to see major changes as new treatment guidelines continue to develop, however, since last published several years ago, these guidelines are helpful because they are based on evidence, which is the basis to a good set of guidelines.

Dr Weber is confident in the decisions highlighted inside new guidelines by organized bodies such as the American Diabetes Association, National Kidney Foundation, and Joint National Committee because he feels that these bodies are putting a lot of effort into creating them.